{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:31:00Z","timestamp":1765837860849},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00101-019-0560-8","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T17:52:34Z","timestamp":1553709154000},"page":"228-238","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Antihypotensiva bei Kaiserschnittentbindungen"],"prefix":"10.1007","volume":"68","author":[{"given":"Daniel","family":"Chappell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Helf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Gayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leopold","family":"Eberhart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kranke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"key":"560_CR1","volume-title":"S3-Leitlinie Intravasale Volumentherapie beim Erwachsenen","author":"Awmf. AWMF Online","year":"2014","unstructured":"Awmf. AWMF Online (2014) S3-Leitlinie Intravasale Volumentherapie beim Erwachsenen. \n                    https:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/001-020l_S3_Intravasale_Volumentherapie_Erwachsenen_2014-09-abgelaufen.pdf\n                    \n                  . Zugegriffen: 31. Juli 2018"},{"key":"560_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ijoa.2004.12.004","volume":"14","author":"M Balki","year":"2005","unstructured":"Balki M, Carvalho JCA (2005) Intraoperative nausea and vomiting during cesarean section under regional anesthesia. Int J Obstet Anesth 14:230\u2013241","journal-title":"Int J Obstet Anesth"},{"key":"560_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3389\/fphar.2017.00068","volume":"8","author":"B Bein","year":"2017","unstructured":"Bein B, Christ T, Eberhart LH (2017) Cafedrine\/Theodrenaline (20:1) Is an Established Alternative for the Management of Arterial Hypotension in Germany\u2014a Review Based on a\u00a0Systematic Literature Search. Front Pharmacol 8:68","journal-title":"Front Pharmacol"},{"key":"560_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002251.pub3","author":"C Chooi","year":"2017","unstructured":"Chooi C, Cox JJ, Lumb RS et\u00a0al (2017) Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD002251.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"560_CR5","first-page":"515","volume":"62","author":"KE Clemens","year":"2010","unstructured":"Clemens KE, Quednau I, Heller AR et\u00a0al (2010) Impact of cafedrine\/theodrenaline (Akrinor\u00ae) on therapy of maternal hypotension during spinal anesthesia for Cesarean delivery: a\u00a0retrospective study. Minerva Ginecol 62:515\u2013524","journal-title":"Minerva Ginecol"},{"key":"560_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002251.pub2","author":"AM Cyna","year":"2006","unstructured":"Cyna AM, Andrew M, Emmett RS et\u00a0al (2006) Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD002251.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"560_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/00000542-198201000-00019","volume":"56","author":"S Datta","year":"1982","unstructured":"Datta S, Alper MH, Ostheimer GW et\u00a0al (1982) Method of ephedrine administration and nausea and hypotension during spinal anesthesia for cesarean section. Anesthesiology 56:68\u201370","journal-title":"Anesthesiology"},{"key":"560_CR8","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.ijoa.2015.08.012","volume":"24","author":"L Gao","year":"2015","unstructured":"Gao L, Zheng G, Han J et al (2015) Effects of prophylactic ondansetron on spinal anesthesia-induced hypotension: a\u00a0meta-analysis. Int J Obstet Anesth 24:335\u2013343","journal-title":"Int J Obstet Anesth"},{"key":"560_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ijoa.2008.11.005","volume":"18","author":"V Laudenbach","year":"2009","unstructured":"Laudenbach V, Mercier FJ, Roze JC et\u00a0al (2009) Anaesthesia mode for caesarean section and mortality in very preterm infants: an epidemiologic study in the EPIPAGE cohort. Int J Obstet Anesth 18:142\u2013149","journal-title":"Int J Obstet Anesth"},{"key":"560_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jclinane.2017.03.026","volume":"31","author":"JE Lee","year":"2017","unstructured":"Lee JE, George RB, Habib AS (2017) Spinal-induced hypotension: Incidence, mechanisms, prophylaxis, and management: Summarizing 20 years of research. Best practice  research. Clin Anaesthesiol 31:57\u201368","journal-title":"Clin Anaesthesiol"},{"key":"560_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/bja\/aev251","volume":"115","author":"FJ Mercier","year":"2015","unstructured":"Mercier FJ (2015) 6\u202f% Hydroxyethyl starch (130\/0.4) vs Ringer\u2019s lactate preloading before spinal anaesthesia for Caesarean delivery. Br J Anaesth 115:328\u2013329","journal-title":"Br J Anaesth"},{"key":"560_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/bja\/aeu103","volume":"113","author":"FJ Mercier","year":"2014","unstructured":"Mercier FJ, Diemunsch P, Ducloy-Bouthors AS et al (2014) 6\u202f% Hydroxyethyl starch (130\/0.4) vs Ringer\u2019s lactate preloading before spinal anaesthesia for Caesarean delivery: the randomized, double-blind, multicentre CAESAR trial. Br J Anaesth 113:459\u2013467","journal-title":"Br J Anaesth"},{"key":"560_CR13","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/00000539-200006000-00024","volume":"90","author":"NWD Kee","year":"2000","unstructured":"Kee NWD, Khaw KS, Lee BB et al (2000) A dose-response study of prophylactic intravenous ephedrine for the prevention of hypotension during spinal anesthesia for cesarean delivery. Anesth Analg 90:1390\u20131395","journal-title":"Anesth Analg"},{"key":"560_CR14","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1097\/00000542-200510000-00012","volume":"103","author":"NWD Kee","year":"2005","unstructured":"Kee NWD, Khaw KS, Ng FF (2005) Prevention of hypotension during spinal anesthesia for cesarean delivery: an effective technique using combination phenylephrine infusion and crystalloid cohydration. Anesthesiology 103:744\u2013750","journal-title":"Anesthesiology"},{"key":"560_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijoa.2014.11.002","volume":"24","author":"ZY Strouch","year":"2015","unstructured":"Strouch ZY, Dakik CG, White WD et al (2015) Anesthetic technique for cesarean delivery and neonatal acid-base status: a\u00a0retrospective database analysis. Int J Obstet Anesth 24:22\u201329","journal-title":"Int J Obstet Anesth"},{"key":"560_CR16","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1111\/j.1399-6576.2011.02646.x","volume":"56","author":"M Veeser","year":"2012","unstructured":"Veeser M, Hofmann T, Roth R et al (2012) Vasopressors for the management of hypotension after spinal anesthesia for elective caesarean section. Systematic review and cumulative meta-analysis. Acta Anaesthesiol Scand 56:810\u2013816","journal-title":"Acta Anaesthesiol Scand"},{"issue":"6","key":"560_CR17","first-page":"515","volume":"62","author":"KE Clemens","year":"2010","unstructured":"Clemens KE, Quednau I, Heller AR, Klaschik E (2010) Impact of cafedrine\/theodrenaline (Akrinor\u00ae) on therapy of maternal hypotension during spinal anesthesia for Cesarean delivery: A\u00a0retrospective study. Minerva Ginecol 62(6):515\u2013524","journal-title":"Minerva Ginecol"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-019-0560-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-019-0560-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-019-0560-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:20:24Z","timestamp":1585182024000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-019-0560-8"}},"subtitle":["Behandlung der arteriellen Hypotension mit Ephedrin, Phenylephrin und Akrinor\u00ae (Cafedrin\/Theodrenalin) im Rahmen von Kaiserschnittentbindungen in Spinalan\u00e4sthesie"],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["560"],"URL":"https:\/\/doi.org\/10.1007\/s00101-019-0560-8","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"20 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"P.\u00a0Kranke ist im Rahmen der Hypotens-Studie (DRKS-ID der Studie: DRKS00010740) Mitglied des Steering Committee und erhielt Vortragshonorare von der Firmen TEVA Ratiopharm und Sintetica. D.\u00a0Chappell erhielt Vortragshonorare der Firmen TEVA Ratiopharm und Sintetica. L.\u00a0Eberhart ist Leiter der Hypotens-Studie (DRKS-ID der Studie: DRKS00010740), Mitglied des Steering Committee und erhielt Vortragshonorare von der Fa. TEVA Ratiopharm. A.\u00a0Helf und J.\u00a0Gayer geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Diese retrospektive Studie erfolgte nach Konsultation einer Ethikkommission und im Einklang mit nationalem Recht.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}